Drug archive
Respiratory Syncytial Virus Immune Globulin Intravenous (Systemic)Proper Use
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Proper Use of This Medicine
Dosing - The dose of respiratory syncytial virus immune globulin intravenous (RSV-IGIV) will be different for different patients. Doses are based on body weight. The following information includes only the average doses of RSV-IGIV.
-
For injection
dosage form:
-
For preventing respiratory syncytial virus (RSV) infection:
- Adults and children 24 months of age and older - Use is not recommended.
- Infants and children younger than 24 months of age - 750 milligrams (mg) per kilogram (kg) (340.9 mg per pound) of body weight injected into a vein once a month for five months.
-
For preventing respiratory syncytial virus (RSV) infection: